| Grant revenues | |
| Research and development | 108.67K |
| General and administrative | |
| Total operating expenses | 1.19M |
| Loss from operations | -1.19M |
| Change in fair value of derivative liabilities | |
| Gain on warrant exchange | |
| Interest income | |
| Interest expense | -2.11K |
| Net loss from continuing operations | |
| Net loss from discontinued operations | |
| Gain on sale of business unit | |
| Net loss | -1.19M |
| Loss per common share - basic and diluted | -0.14 |
| Weighted average common shares outstanding | |